Document Detail


GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity.
MedLine Citation:
PMID:  9357964     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
GAS6, a gene previously identified as growth arrest specific, has been demonstrated to be the ligand of Axl, a novel tyrosine kinase receptor widely expressed in both normal and neoplastic hematopoietic tissue. We have observed previously that GAS6 mRNA was present in whole bone marrow. This preliminary finding prompted us to investigate the presence of GAS6 in hematopoietic tissue and the possible role of this molecule in controlling the proliferation of hematopoietic precursors. We report here that the protein GAS6 is diffusely present in hematopoietic tissue, both in stromal and in hematopoietic cells, and that, among these cells, positivity is observed in megakaryocytes and myelomonocytic precursors. Furthermore, our data suggest that GAS6 is not a growth factor for hematopoietic progenitors or stromal fibroblasts. Despite the fact that both the Axl receptor and its ligand, GAS6, are expressed in hematopoietic tissue, the biological role of their interactions remains to be determined.
Authors:
G C Avanzi; M Gallicchio; G Cavalloni; L Gammaitoni; F Leone; A Rosina; R Boldorini; G Monga; L Pegoraro; B Varnum; M Aglietta
Related Documents :
2842344 - Regulation of gene expression of myeloperoxidase during myeloid differentiation.
17218384 - Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights cyp26 cytochr...
25253654 - Temporal expression of hyaluronic acid and hyaluronic acid receptors in a porcine small...
15501994 - Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resista...
18941504 - Birdsong "transcriptomics": neurochemical specializations of the oscine song system.
11416864 - Developmental regulation of an instability element from the drosophila fushi tarazu mrna.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Experimental hematology     Volume:  25     ISSN:  0301-472X     ISO Abbreviation:  Exp. Hematol.     Publication Date:  1997 Nov 
Date Detail:
Created Date:  1997-11-20     Completed Date:  1997-11-20     Revised Date:  2010-06-02    
Medline Journal Info:
Nlm Unique ID:  0402313     Medline TA:  Exp Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1219-26     Citation Subset:  IM    
Affiliation:
Dipartimento di Scienze Mediche, Facolt? di Medicina di Novara, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biopsy
Bone Marrow Cells / metabolism*
Cell Division / drug effects
Cells, Cultured
Fibroblasts / cytology
Gene Expression
Hematopoiesis*
Hematopoietic Cell Growth Factors / pharmacology
Humans
Intercellular Signaling Peptides and Proteins*
Mitogens
Oncogene Proteins / physiology
Proteins / genetics,  metabolism*
RNA, Messenger / genetics
Receptor Protein-Tyrosine Kinases / physiology
Recombinant Proteins / pharmacology
Chemical
Reg. No./Substance:
0/Hematopoietic Cell Growth Factors; 0/Intercellular Signaling Peptides and Proteins; 0/Mitogens; 0/Oncogene Proteins; 0/Proteins; 0/RNA, Messenger; 0/Recombinant Proteins; 0/growth arrest-specific protein 6; EC 2.7.1.-/TYRO3 protein, human; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases; EC 2.7.10.1/axl receptor tyrosine kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Theoretical study of the electrostatic and steric effects on the spectroscopic characteristics of th...
Next Document:  Expression of the human major vault protein LRP in acute myeloid leukemia.